PSTV
Plus Therapeutics Inc
NASDAQ: PSTV · HEALTHCARE · BIOTECHNOLOGY
$5.60
-5.88% today
Updated 2026-04-29
Market cap
$40.83M
P/E ratio
—
P/S ratio
7.83x
EPS (TTM)
$-7.25
Dividend yield
—
52W range
$3 – $24
Volume
3.6M
Plus Therapeutics Inc (PSTV) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+47.9%
Last 4 quarters
Revenue YoY growth
-3.2%
Most recent quarter
EPS YoY growth
+91.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.5%
2026-03-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-13 | $-0.04 | +95.5% | $0.29 | $0.26 | -11.5% |
| 2025-10-30 | $-0.04 | +94.3% | $0.54 | $0.54 | +0.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.92 | $-0.04 | +95.5% | $1.37M | -3.2% |
| 2025-09-30 | $-0.70 | $-0.04 | +94.3% | $1.40M | -4.1% |
| 2025-06-30 | $-0.13 | $-0.01 | +95.0% | $1.39M | +8.7% |
| 2025-03-31 | $-0.29 | $-0.57 | -93.3% | $1.06M | -36.9% |
| 2024-12-31 | $-0.50 | $-0.49 | +1.3% | $1.41M | +7.5% |
| 2024-09-30 | $-0.56 | $-0.37 | +33.9% | $1.46M | +17.4% |
| 2024-06-30 | $-0.53 | $-0.56 | -5.7% | $1.28M | -31.0% |
| 2024-03-31 | $-1.09 | $-0.75 | +31.2% | $1.68M | +231.4% |
| 2023-12-31 | $-1.07 | $-0.84 | +21.5% | $1.31M | — |
| 2023-09-30 | $-1.12 | $-1.00 | +10.7% | $1.24M | — |
| 2023-06-30 | $-1.91 | $-0.59 | +69.1% | $1.85M | — |
| 2023-03-31 | $-0.13 | $-0.14 | -7.7% | $506000.00 | — |
Frequently asked questions
Has Plus Therapeutics Inc beaten earnings estimates?
Plus Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +47.9% over the last 4 quarters.
How does PSTV stock react to earnings?
PSTV stock has moved an average of -5.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Plus Therapeutics Inc's revenue growth rate?
Plus Therapeutics Inc reported year-over-year revenue growth of -3.2% in its most recent quarter, with EPS growing +91.6% year-over-year.